Russia to join international medical device single audit program; pilot due in Australia, Brazil, Canada and US
This article was originally published in SRA
Russia has signaled it will join the medical device single audit program (MDSAP) that international regulators are developing to streamline the oversight of manufacturing facilities and which is set to undergo a pilot in Australia, Brazil, Canada and the US1,2.
You may also be interested in...
The European Medicines Agency will continue working over the Christmas period so that it can complete its assessment of the newly filed marketing applications for BioNTech/Pfizer’s and Moderna’s COVID-19 vaccines as soon possible.
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
New medicines under evaluation at the European Medicines Agency.